Xtant Medical Holdings (XTNT) Depreciation & Amortization (CF) (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $1.2 million in Q3 2025.

• On a quarterly basis, Depreciation & Amortization (CF) rose 8.2% year-over-year to $1.2 million in Q3 2025; TTM through Dec 2025 was $3.4 million, a 19.41% decrease from a year earlier, with the FY2024 full-year figure at $4.2 million, up 33.08% from the prior year.
• Depreciation & Amortization (CF) for Q3 2025 stood at $1.2 million, down from $1.2 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for XTNT reached as high as $1.2 million in Q2 2025 and fell as low as $281000.0 in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $706631.6 across 5 years, with a median of $803000.0 in 2023.
• Across the five-year window, Depreciation & Amortization (CF) slumped 45.26% in 2021 and soared 216.82% in 2023, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $291000.0 in 2021, then gained by 10.31% to $321000.0 in 2022, then surged by 216.82% to $1.0 million in 2023, then grew by 12.88% to $1.1 million in 2024, then grew by 1.13% to $1.2 million in 2025.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.2 million in Q3 2025, $1.2 million in Q2 2025, and $1.1 million in Q1 2025.